Literature DB >> 2400884

Radiation therapy in the management of giant lymph node hyperplasia.

T Sethi1, K Joshi, S C Sharma, B D Gupta.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2400884     DOI： 10.1259/0007-1285-63-752-648

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  9 in total

Review 1.  Neoadjuvant radiotherapy of primary irresectable unicentric Castleman's disease: a case report and review of the literature.

Authors:  Iris A C de Vries; Marjolein M S van Acht; Thomas B J Demeyere; Marnix L M Lybeert; Jean-Paul de Zoete; Grard A P Nieuwenhuijzen
Journal:  Radiat Oncol       Date:  2010-02-02       Impact factor: 3.481

2.  The clinical spectrum of Castleman's disease.

Authors:  Angela Dispenzieri; James O Armitage; Matt J Loe; Susan M Geyer; Jake Allred; John K Camoriano; David M Menke; Dennis D Weisenburger; Kay Ristow; Ahmet Dogan; Thomas M Habermann
Journal:  Am J Hematol       Date:  2012-07-13       Impact factor: 10.047

3.  Cases report of unicentric Castleman's disease: revisit of radiotherapy role.

Authors:  O Kyu Noh; Sang-Wook Lee; Jae Whan Lee; Sang Yoon Kim; Chung Soo Kim; Eun Kyung Choi; Jong Hoon Kim; Seung Do Ahn
Journal:  Radiat Oncol J       Date:  2013-03-31

4.  International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.

Authors:  Frits van Rhee; Eric Oksenhendler; Gordan Srkalovic; Peter Voorhees; Megan Lim; Angela Dispenzieri; Makoto Ide; Sophia Parente; Stephen Schey; Matthew Streetly; Raymond Wong; David Wu; Ivan Maillard; Joshua Brandstadter; Nikhil Munshi; Wilbur Bowne; Kojo S Elenitoba-Johnson; Alexander Fössa; Mary Jo Lechowicz; Shanmuganathan Chandrakasan; Sheila K Pierson; Amy Greenway; Sunita Nasta; Kazuyuki Yoshizaki; Razelle Kurzrock; Thomas S Uldrick; Corey Casper; Amy Chadburn; David C Fajgenbaum
Journal:  Blood Adv       Date:  2020-12-08

5.  Intra-abdominal localized hyaline-vascular Castleman disease: imaging characteristics and management of a rare condition.

Authors:  Nikolaos Vassos; Dimitrios Raptis; Michael Lell; Peter Klein; Aristotelis Perrakis; Jens Köhler; Roland S Croner; Werner Hohenberger; Abbas Agaimy
Journal:  Arch Med Sci       Date:  2016-02-02       Impact factor: 3.318

6.  Resection of unicentric interlobar Castleman disease with following adjuvant radiotherapy.

Authors:  Bruno Sarana; Jana Jaal; Hannes Tamm; Tanel Laisaar
Journal:  SAGE Open Med Case Rep       Date:  2017-11-30

7.  Castleman disease.

Authors:  Ibrahiem Saeed-Abdul-Rahman; Ali M Al-Amri
Journal:  Korean J Hematol       Date:  2012-09-25

Review 8.  Castleman's disease in the head of the pancreas: report of a rare clinical entity and current perspective on diagnosis, treatment, and outcome.

Authors:  Hongbei Wang; Rosemary L Wieczorek; Michael E Zenilman; Fidelina Desoto-Lapaix; Bimal C Ghosh; Wilbur B Bowne
Journal:  World J Surg Oncol       Date:  2007-11-20       Impact factor: 2.754

9.  Retroperitoneal Castleman's disease: advocating a multidisciplinary approach for a rare clinical entity.

Authors:  Austin D Williams; Adriana Sanchez; Jun Steve Hou; Rene Rothstein Rubin; Mark E Hysell; Blake D Babcock; Mohammad F Shaikh; Michael S Weingarten; Wilbur B Bowne
Journal:  World J Surg Oncol       Date:  2014-02-04       Impact factor: 2.754
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.